Invention Grant
- Patent Title: Aza-dihydro-acridone derivatives
-
Application No.: US16493826Application Date: 2018-03-14
-
Publication No.: US11434239B2Publication Date: 2022-09-06
- Inventor: Andrés Gagete Mateos , Damiá Tormo Carulla , Luc Marti Clauzel , Julio Castro Palomino
- Applicant: Artax Biopharma Inc.
- Applicant Address: US MA Cambridge
- Assignee: Artax Biopharma Inc.
- Current Assignee: Artax Biopharma Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Dechert LLP
- Agent Andrea L.C. Reid; Gang Wang
- Priority: EP17382129 20170314
- International Application: PCT/US2018/022320 WO 20180314
- International Announcement: WO2018/170048 WO 20180920
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P37/00
Abstract:
Aza-dihydro-acridone derivatives of formula I, wherein the meaning of R1, R′1, R2 and R3 is that specified in the description, to be used as T cells proliferation inhibitors.
Public/Granted literature
- US20200079768A1 AZA-DIHYDRO-ACRIDONE DERIVATIVES Public/Granted day:2020-03-12
Information query
